NCT05493826 Real World Study on the Use of Cemiplimab in Adult Patients in UK Status COMPLETED Phase N/A
NCT05492578 Long-Term Safety and Efficacy Evaluation of Amlitelimab in Participants of Previous Amlitelimab Moderate to Severe Atopic Dermatitis Clinical Trials Status ENROLLING_BY_INVITATION Phase PHASE2/PHASE3
NCT05468320 Caplacizumab and Immunosuppressive Therapy Without Firstline Therapeutic Plasma Exchange in Adults With Immune-mediated Thrombotic Thrombocytopenic Purpura Status COMPLETED Phase PHASE3
NCT05453942 A Study to Investigate Safety, Tolerability and Clinical Response With SAR441566 Compared With Placebo in Participants With Mild to Moderate Psoriasis Status COMPLETED Phase PHASE1
NCT05450562 Dose Escalation and Expansion Study of SAR444200-based Regimen in Adult Participants With Advanced Solid Tumors Status TERMINATED Phase PHASE1/PHASE2
NCT05442645 A Study in Male and Female Adult Patients With Atopic Dermatitis Treated With Dupilumab in Taiwan Status COMPLETED Phase N/A
NCT05429762 Effect of Tusamitamab Ravtansine on QTc Interval in Participants With Metastatic Solid Tumors Status TERMINATED Phase PHASE1
NCT05421598 Dose Ranging Study of Amlitelimab in Adult Participants With Moderate-to-severe Asthma Status COMPLETED Phase PHASE2
NCT05406180 Postmarketing Surveillance Study for Quadrivalent Influenza Vaccine (VaxigripTetra Inj.) in Subjects Aged 3 Years Old and Above Status COMPLETED Phase N/A
NCT05405166 SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05366764 First-in-human Study of SAR443765 in Healthy Participants and in Asthmatic Participants Status COMPLETED Phase PHASE1
NCT05359276 Data Analysis of Adult and Pediatric Participants With Acid Sphingomyelinase Deficiency (ASMD) on Early Access to Olipudase Alfa in France Status COMPLETED Phase N/A
NCT05326412 Mechanistic Study of the Effect of Itepekimab on Airway Inflammation in Patients With COPD Status COMPLETED Phase PHASE2
NCT05302297 Comparative Efficacy of Cemiplimab to Historical Standard of Care in France Status COMPLETED Phase N/A
NCT05298683 A Phase 2 Study of Isatuximab in Combination With Pomalidomide and Dexamethasone in MM Patients Who Received One Prior Line of Therapy Containing Lenalidomide and a Proteasome Inhibitor Status NOT_YET_RECRUITING Phase PHASE2
NCT05283915 Study to Assess the Plasma Concentration of Tolebrutinib Given as a Tablet to Adult Participants With Mild Hepatic Impairment Compared to Participants With Normal Hepatic Function Status COMPLETED Phase PHASE1
NCT05282030 Study to Assess the Plasma Concentration of Tolebrutinib Given as a Tablet to Adult Participants With Renal Impairment Compared to Healthy Participants. Status COMPLETED Phase PHASE1
NCT05280548 A Study to Evaluate the Effect of Venglustat Tablets on Left Ventricular Mass Index in Male and Female Adult Participants With Fabry Disease Status ACTIVE_NOT_RECRUITING Phase PHASE3